Colorectal cancer: Review of signaling pathways and associated therapeutic strategies

被引:8
|
作者
Leiphrakpam, Premila D. [1 ,2 ]
Rajappa, Senthil J. [3 ]
Krishnan, Mridula [4 ]
Batra, Rishi [5 ]
Murthy, Shilpa S. [6 ]
Are, Chandrakanth [1 ,2 ,7 ]
机构
[1] Univ Nebraska Med Ctr, Coll Med, Grad Med Educ, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE USA
[3] Basavatarakam Indo Amer Canc Hosp, Med Oncol, Hyderabad, Telangana, India
[4] Univ Nebraska Med Ctr, Coll Med, Dept Internal Med, Div Oncol & Hematol, Omaha, NE USA
[5] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Gen Surg, Omaha, NE USA
[6] Mem Sloan Kettering Canc Ctr, Div Surg Oncol, Global Canc Dispar Initiat, New York, NY USA
[7] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE 68198 USA
关键词
biomarkers; colorectal cancer; targeted therapy; RANDOMIZED PHASE-III; FOLFIRI PLUS BEVACIZUMAB; MOLECULAR SUBGROUP ANALYSES; FACTOR-BETA RECEPTOR; KRAS WILD-TYPE; OPEN-LABEL; 1ST-LINE TREATMENT; FOLFOXIRI PLUS; DOUBLE-BLIND; MAINTENANCE TREATMENT;
D O I
10.1002/jso.27295
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor profiling and targeted therapy revolutionized the treatment strategies of metastatic colorectal cancer (mCRC) in the last decade. The heterogeneity of CRC tumors plays a critical role in the development of treatment resistance, which underscores the need to understand the molecular mechanism involved in CRC to develop novel targeted therapeutic strategies. This review provides an overview of the signaling pathways driving CRC, the existing targeted agents, their limitations, and future trends.
引用
收藏
页码:1277 / 1295
页数:19
相关论文
共 50 条
  • [21] Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis
    Bertaud, Alexandrine
    Joshkon, Ahmad
    Heim, Xavier
    Bachelier, Richard
    Bardin, Nathalie
    Leroyer, Aurelie S.
    Blot-Chabaud, Marcel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [22] Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
    Karam, Caline S.
    Ballon, Jacob S.
    Bivens, Nancy M.
    Freyberg, Zachary
    Girgis, Ragy R.
    Lizardi-Ortiz, Jose E.
    Markx, Sander
    Lieberman, Jeffrey A.
    Javitch, Jonathan A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (08) : 381 - 390
  • [23] Mitochondria as the decision makers for cancer cell fate: from signaling pathways to therapeutic strategies
    Genovese, Ilaria
    Vezzani, Bianca
    Danese, Alberto
    Modesti, Lorenzo
    Vitto, Veronica Angela Maria
    Corazzi, Virginia
    Pelucchi, Stefano
    Pinton, Paolo
    Giorgi, Carlotta
    CELL CALCIUM, 2020, 92
  • [24] TNF-Dependent Signaling Pathways in Liver Cancer: Promising Targets for Therapeutic Strategies?
    Roderburg, Christoph
    Gautheron, Jeremie
    Luedde, Tom
    DIGESTIVE DISEASES, 2012, 30 (05) : 500 - 507
  • [25] Examination of Downregulated miRNAs and Associated Pathways in Colorectal Cancer: A Systematic Review
    Khalyfa, Ahamed
    Randhawa, Navkiran
    Khalyfa, Abdelnaby
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S108 - S109
  • [26] Stem Cell Signaling Pathways in Colorectal Cancer
    Ramakrishna, B. S.
    Kumar, Sam Vijay
    CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (04) : 341 - 349
  • [27] Signaling pathways involved in colorectal cancer progression
    Koveitypour, Zahra
    Panahi, Farnoush
    Vakilian, Mehrdad
    Peymani, Maryam
    Forootan, Farzad Seyed
    Esfahani, Mohammad Hossein Nasr
    Ghaedi, Kamran
    CELL AND BIOSCIENCE, 2019, 9 (01):
  • [28] Signaling pathways involved in colorectal cancer progression
    Zahra Koveitypour
    Farnoush Panahi
    Mehrdad Vakilian
    Maryam Peymani
    Farzad Seyed Forootan
    Mohammad Hossein Nasr Esfahani
    Kamran Ghaedi
    Cell & Bioscience, 9
  • [29] Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options
    Damin, Daniel C.
    Lazzaron, Anderson R.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (04) : 877 - 887
  • [30] Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options
    Daniel C Damin
    Anderson R Lazzaron
    World Journal of Gastroenterology, 2014, (04) : 877 - 887